QA: TENAX THERAPEUTICS INC. in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000034956_2017_TENAX_THERAPEUTICS_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0000034956')"}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000034956, TENAX THERAPEUTICS INC.

  xvar xval
0 AssetsCurrent 13,628,175
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 19,105
3 remainder_Assets 9,692,895
4 LiabilitiesCurrent 6,199,237
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 6,245,958
9 ResearchAndDevelopmentExpense 13,139,681
10 remainder_Expenses 25,303,000
11 remainder_Revenues 0
12 remainder_NetIncome 764,735
13 remainder_ComprehensiveNetIncome 87,737,084
  yvar yval
0 Assets 23,340,175
1 Liabilities 6,199,237
2 Expenses 44,688,639
3 Revenues 0
4 StockholdersEquity 17,140,938
5 NetIncome -43,923,904
6 ComprehensiveNetIncome -55,362
7 BaseVar 81,364,935
8 EconomicCapitalRatio 1.99

Edgar->Model Mapping

Feature Distribution